ArticleJournal of obesity & metabolic syndrome2021

Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21).

Ju-Young Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.